Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study

BACKGROUND: The advent of targeted therapies in the past 7 years has extended median survival for metastatic renal-cell carcinoma. This improvement in clinical outcome has created a need for new, more accurate prognostic measures. We assessed the use of conditional survival—a measure that accounts f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Harshman, Lauren C, Xie, Wanling, Bjarnason, Georg A, Knox, Jennifer J, MacKenzie, Mary, Wood, Lori, Srinivas, Sandy, Vaishampayan, Ulka N, Tan, Min-Han, Rha, Sun-Young, Donskov, Frede, Agarwal, Neeraj, Kollmannsberger, Christian, North, Scott, Rini, Brian I, Heng, Daniel Y C, Choueiri, Toni K
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3856362/
https://ncbi.nlm.nih.gov/pubmed/22877847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(12)70285-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars